Research and Development
Research and Development
Innovating Drug Discovery through Translational R&D
VIVISCIENCES drives early drug discovery with integrated in vivo, in vitro, and in silico platforms, ensuring rapid, translational preclinical development.
Translational Research & Development
Our integrated platforms streamline the path from research to preclinical stages.
VIVISCIENCES Services
VIVISCIENCES unites experimental and computational methods to drive drug discovery.
Advancing Innovation
We ensure data-driven decisions grounded in science and aligned with regulations.
Polyclonal Antibody Development
Our research facility specializes in the development of high-quality polyclonal antibodies using well-established in vivo models, primarily in rats and rabbits. We ensure robust immunization protocols, optimized antigen preparation, and stringent quality control measures to deliver reliable antibody solutions for preclinical research applications.
Disease Models for Pharmacological Screening
We specialize in preclinical disease model development, accelerating the discovery of innovative therapeutic agents. Our expertise spans oncology, metabolic and endocrine disorders, gastrointestinal, inflammatory, reproductive, and organ-protective pharmacology.
From cancer and diabetes to wound healing and antimicrobial screening, our integrated in vivo platforms ensure rigorous evaluation and rapid lead identification for next-generation treatments.
In Vitro Pharmacology & Toxicology
We offer a comprehensive suite of cell-based assays to evaluate the efficacy, safety, and mechanistic profiles of investigational compounds. Our capabilities span cytotoxicity, viability, apoptosis, and mechanistic toxicity studies, including mitochondrial and oxidative stress assessments. Leveraging advanced 3D cell cultures and organoids, we provide physiologically relevant platforms for drug screening and disease modeling. Complementing this, our ADME studies, hERG cardiotoxicity, and CYP450 interaction assays deliver critical insights for drug safety and development success.
Drug Discovery Support
VIVISCIENCES delivers end-to-end drug discovery solutions by integrating experimental biology with advanced computational modeling. From target identification and validation to high-throughput screening (HTS), we accelerate hit discovery and lead optimization through SAR studies. Our in silico tools, including molecular docking, virtual screening, and pharmacophore modeling, streamline compound design and predict ligand–target interactions. This integrated workflow ensures rapid, efficient, and scientifically robust early-stage drug development.
10
+
Years Experience
395
+
Projects Done
50
+
Portfolios
Plan to Start a Project